Sergio Rodriguez
#14|Guard|Born June 12, 1986
6-3
Height
176 lbs
Weight
11 yrs
Experience
March 2017
| Date↓ | TM | OPP | Result | MIN | PTS | REB | OREB | DREB | AST | STL | BLK | TOV | PF | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | TS% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2017 | PHI | @ IND | L 94-107 | 24 | 16 | 1 | 0 | 1 | 2 | 2 | 0 | 2 | 2 | 6 | 9 | 66.7 | 4 | 6 | 66.7 | 0 | 0 | 0.0 | 88.9 | +7 |
| Mar 24, 2017 | PHI | @ CHI | W 117-107 | 22 | 12 | 4 | 0 | 4 | 7 | 1 | 0 | 2 | 1 | 5 | 10 | 50.0 | 2 | 5 | 40.0 | 0 | 0 | 0.0 | 60.0 | +10 |
| Mar 22, 2017 | PHI | @ OKC | L 97-122 | 26 | 6 | 1 | 0 | 1 | 4 | 1 | 0 | 1 | 0 | 3 | 5 | 60.0 | 0 | 1 | 0.0 | 0 | 0 | 0.0 | 60.0 | -8 |
| Mar 20, 2017 | PHI | @ ORL | L 109-112 | 19 | 0 | 3 | 1 | 2 | 4 | 0 | 0 | 0 | 1 | 0 | 8 | 0.0 | 0 | 1 | 0.0 | 0 | 0 | 0.0 | 0.0 | 0 |
| Mar 19, 2017 | PHI | vs BOS | W 105-99 | 20 | 9 | 3 | 1 | 2 | 7 | 1 | 0 | 2 | 3 | 4 | 6 | 66.7 | 1 | 2 | 50.0 | 0 | 0 | 0.0 | 75.0 | +3 |
| Mar 17, 2017 | PHI | vs DAL | W 116-74 | 26 | 13 | 4 | 1 | 3 | 6 | 0 | 0 | 0 | 4 | 5 | 5 | 100.0 | 2 | 2 | 100.0 | 1 | 2 | 50.0 | 110.5 | +8 |
| Mar 14, 2017 | PHI | @ GSW | L 104-106 | 17 | 3 | 1 | 1 | 0 | 3 | 0 | 0 | 0 | 2 | 1 | 7 | 14.3 | 1 | 6 | 16.7 | 0 | 0 | 0.0 | 21.4 | -14 |
| Mar 12, 2017 | PHI | @ LAL | W 118-116 | 18 | 3 | 1 | 1 | 0 | 4 | 0 | 0 | 2 | 0 | 1 | 6 | 16.7 | 1 | 3 | 33.3 | 0 | 0 | 0.0 | 25.0 | -15 |
| Mar 11, 2017 | PHI | @ LAC | L 100-112 | 18 | 4 | 2 | 0 | 2 | 8 | 0 | 0 | 3 | 0 | 2 | 5 | 40.0 | 0 | 2 | 0.0 | 0 | 0 | 0.0 | 40.0 | -7 |
| Mar 09, 2017 | PHI | @ POR | L 108-114 | 22 | 8 | 1 | 0 | 1 | 6 | 0 | 0 | 0 | 3 | 3 | 9 | 33.3 | 1 | 4 | 25.0 | 1 | 2 | 50.0 | 40.5 | +6 |
| Mar 06, 2017 | PHI | vs MIL | L 98-112 | 24 | 5 | 3 | 0 | 3 | 8 | 0 | 0 | 0 | 3 | 2 | 7 | 28.6 | 1 | 4 | 25.0 | 0 | 0 | 0.0 | 35.7 | +5 |
| Mar 04, 2017 | PHI | vs DET | L 106-136 | 30 | 12 | 1 | 0 | 1 | 8 | 0 | 0 | 2 | 1 | 4 | 7 | 57.1 | 4 | 6 | 66.7 | 0 | 0 | 0.0 | 85.7 | -12 |
| Mar 03, 2017 | PHI | vs NYK | W 105-102 | 16 | 1 | 0 | 0 | 0 | 3 | 2 | 0 | 3 | 0 | 0 | 5 | 0.0 | 0 | 2 | 0.0 | 1 | 2 | 50.0 | 8.5 | +14 |
| Mar 01, 2017 | PHI | @ MIA | L 98-125 | 18 | 10 | 1 | 1 | 0 | 2 | 0 | 0 | 0 | 1 | 5 | 10 | 50.0 | 0 | 0 | 0.0 | 0 | 0 | 0.0 | 50.0 | -10 |
| Monthly Average | 14G | 21.4 | 7.3 | 1.9 | 0.4 | 1.4 | 5.1 | 0.5 | 0 | 1.2 | 1.5 | 2.9 | 7.1 | 41.4 | 1.2 | 3.1 | 38.6 | 0.2 | 0.4 | 50.0 | 50.2 | - |
February 2017
| Date↓ | TM | OPP | Result | MIN | PTS | REB | OREB | DREB | AST | STL | BLK | TOV | PF | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | TS% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2017 | PHI | vs GSW | L 108-119 | 28 | 10 | 5 | 0 | 5 | 4 | 0 | 0 | 1 | 2 | 4 | 12 | 33.3 | 2 | 7 | 28.6 | 0 | 0 | 0.0 | 41.7 | +1 |
| Feb 25, 2017 | PHI | @ NYK | L 109-110 | 15 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 8 | 12.5 | 0 | 2 | 0.0 | 0 | 0 | 0.0 | 12.5 | -7 |
| Feb 24, 2017 | PHI | vs WAS | W 120-112 | 18 | 2 | 2 | 0 | 2 | 8 | 0 | 0 | 1 | 1 | 1 | 7 | 14.3 | 0 | 2 | 0.0 | 0 | 0 | 0.0 | 14.3 | +7 |
| Feb 15, 2017 | PHI | @ BOS | L 108-116 | 20 | 8 | 3 | 0 | 3 | 5 | 0 | 0 | 2 | 1 | 3 | 7 | 42.9 | 2 | 3 | 66.7 | 0 | 0 | 0.0 | 57.1 | +7 |
| Feb 13, 2017 | PHI | @ CHA | W 105-99 | 12 | 8 | 0 | 0 | 0 | 3 | 0 | 0 | 2 | 3 | 3 | 5 | 60.0 | 2 | 3 | 66.7 | 0 | 0 | 0.0 | 80.0 | +2 |
| Feb 11, 2017 | PHI | vs MIA | W 117-109 | 16 | 4 | 2 | 0 | 2 | 5 | 1 | 0 | 0 | 1 | 1 | 5 | 20.0 | 0 | 2 | 0.0 | 2 | 2 | 100.0 | 34.0 | -5 |
| Feb 09, 2017 | PHI | @ ORL | W 112-111 | 18 | 12 | 3 | 0 | 3 | 5 | 0 | 0 | 4 | 0 | 4 | 7 | 57.1 | 4 | 4 | 100.0 | 0 | 0 | 0.0 | 85.7 | +13 |
| Feb 08, 2017 | PHI | vs SAS | L 103-111 | 17 | 2 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 2 | 1 | 7 | 14.3 | 0 | 5 | 0.0 | 0 | 0 | 0.0 | 14.3 | +3 |
| Feb 06, 2017 | PHI | @ DET | L 96-113 | 18 | 10 | 2 | 0 | 2 | 3 | 1 | 0 | 1 | 2 | 4 | 8 | 50.0 | 2 | 4 | 50.0 | 0 | 0 | 0.0 | 62.5 | +6 |
| Feb 04, 2017 | PHI | @ MIA | L 102-125 | 12 | 10 | 1 | 0 | 1 | 1 | 0 | 0 | 2 | 1 | 4 | 7 | 57.1 | 2 | 2 | 100.0 | 0 | 0 | 0.0 | 71.4 | -11 |
| Feb 02, 2017 | PHI | @ SAS | L 86-102 | 17 | 8 | 2 | 0 | 2 | 4 | 2 | 0 | 4 | 2 | 3 | 7 | 42.9 | 1 | 1 | 100.0 | 1 | 2 | 50.0 | 50.8 | 0 |
| Feb 01, 2017 | PHI | @ DAL | L 95-113 | 13 | 5 | 2 | 0 | 2 | 4 | 0 | 0 | 0 | 1 | 2 | 6 | 33.3 | 1 | 4 | 25.0 | 0 | 0 | 0.0 | 41.7 | -10 |
| Monthly Average | 12G | 17 | 6.8 | 1.9 | 0 | 1.9 | 3.7 | 0.4 | 0 | 1.5 | 1.4 | 2.6 | 7.2 | 36.0 | 1.3 | 3.3 | 41.0 | 0.3 | 0.3 | 75.0 | 46.4 | - |
January 2017
| Date↓ | TM | OPP | Result | MIN | PTS | REB | OREB | DREB | AST | STL | BLK | TOV | PF | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | TS% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2017 | PHI | vs SAC | W 122-119 | 14 | 5 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 2 | 5 | 40.0 | 1 | 3 | 33.3 | 0 | 0 | 0.0 | 50.0 | +6 |
| Jan 29, 2017 | PHI | @ CHI | L 108-121 | 6 | 3 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 2 | 50.0 | 1 | 2 | 50.0 | 0 | 0 | 0.0 | 75.0 | -12 |
| Jan 27, 2017 | PHI | vs HOU | L 118-123 | 20 | 8 | 0 | 0 | 0 | 2 | 2 | 0 | 2 | 1 | 3 | 7 | 42.9 | 2 | 5 | 40.0 | 0 | 1 | 0.0 | 53.8 | -9 |
| Jan 25, 2017 | PHI | @ MIL | W 114-109 | 18 | 4 | 0 | 0 | 0 | 7 | 0 | 0 | 2 | 1 | 1 | 1 | 100.0 | 1 | 1 | 100.0 | 1 | 2 | 50.0 | 106.4 | -2 |
| Jan 24, 2017 | PHI | vs LAC | W 121-110 | 20 | 9 | 3 | 0 | 3 | 7 | 0 | 0 | 1 | 0 | 4 | 12 | 33.3 | 1 | 5 | 20.0 | 0 | 0 | 0.0 | 37.5 | +22 |
| Jan 20, 2017 | PHI | vs POR | W 93-92 | 17 | 4 | 1 | 0 | 1 | 2 | 1 | 0 | 0 | 4 | 2 | 7 | 28.6 | 0 | 2 | 0.0 | 0 | 0 | 0.0 | 28.6 | -20 |
| Jan 18, 2017 | PHI | vs TOR | W 94-89 | 19 | 4 | 7 | 1 | 6 | 4 | 0 | 0 | 3 | 0 | 2 | 5 | 40.0 | 0 | 3 | 0.0 | 0 | 1 | 0.0 | 36.8 | +4 |
| Jan 16, 2017 | PHI | @ MIL | W 113-104 | 32 | 10 | 5 | 0 | 5 | 6 | 1 | 0 | 3 | 1 | 4 | 10 | 40.0 | 1 | 6 | 16.7 | 1 | 1 | 100.0 | 47.9 | +16 |
| Jan 14, 2017 | PHI | @ WAS | L 93-109 | 20 | 3 | 1 | 0 | 1 | 2 | 1 | 0 | 0 | 2 | 1 | 6 | 16.7 | 1 | 3 | 33.3 | 0 | 0 | 0.0 | 25.0 | -11 |
| Jan 13, 2017 | PHI | vs CHA | W 102-93 | 16 | 11 | 1 | 0 | 1 | 4 | 2 | 0 | 2 | 1 | 4 | 7 | 57.1 | 2 | 5 | 40.0 | 1 | 1 | 100.0 | 73.9 | 0 |
| Jan 11, 2017 | PHI | vs NYK | W 98-97 | 14 | 2 | 1 | 1 | 0 | 4 | 0 | 0 | 3 | 0 | 1 | 7 | 14.3 | 0 | 3 | 0.0 | 0 | 0 | 0.0 | 14.3 | -1 |
| Jan 08, 2017 | PHI | @ BKN | W 105-95 | 12 | 4 | 0 | 0 | 0 | 3 | 0 | 0 | 1 | 1 | 2 | 6 | 33.3 | 0 | 0 | 0.0 | 0 | 0 | 0.0 | 33.3 | +1 |
| Monthly Average | 12G | 17.3 | 5.6 | 1.6 | 0.2 | 1.4 | 3.6 | 0.6 | 0 | 1.6 | 1 | 2.3 | 6.3 | 36.0 | 0.8 | 3.2 | 26.3 | 0.3 | 0.5 | 50.0 | 42.9 | - |
December 2016
| Date↓ | TM | OPP | Result | MIN | PTS | REB | OREB | DREB | AST | STL | BLK | TOV | PF | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | TS% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2016 | PHI | @ UTA | L 83-100 | 16 | 3 | 2 | 0 | 2 | 2 | 0 | 0 | 3 | 0 | 1 | 6 | 16.7 | 1 | 4 | 25.0 | 0 | 0 | 0.0 | 25.0 | -5 |
| Dec 26, 2016 | PHI | @ SAC | L 100-102 | 25 | 18 | 3 | 0 | 3 | 5 | 3 | 0 | 2 | 1 | 7 | 9 | 77.8 | 4 | 5 | 80.0 | 0 | 0 | 0.0 | 100.0 | +4 |
| Dec 23, 2016 | PHI | @ PHX | L 116-123 | 26 | 21 | 2 | 1 | 1 | 7 | 0 | 0 | 3 | 2 | 8 | 12 | 66.7 | 4 | 8 | 50.0 | 1 | 1 | 100.0 | 84.4 | -2 |
| Dec 20, 2016 | PHI | vs NOP | L 93-108 | 31 | 9 | 2 | 0 | 2 | 3 | 1 | 0 | 0 | 2 | 3 | 11 | 27.3 | 2 | 7 | 28.6 | 1 | 2 | 50.0 | 37.9 | -3 |
| Dec 18, 2016 | PHI | vs BKN | W 108-107 | 23 | 9 | 2 | 1 | 1 | 5 | 1 | 0 | 2 | 3 | 3 | 11 | 27.3 | 3 | 5 | 60.0 | 0 | 0 | 0.0 | 40.9 | -7 |
| Dec 16, 2016 | PHI | vs LAL | L 89-100 | 25 | 4 | 5 | 1 | 4 | 3 | 1 | 0 | 2 | 2 | 2 | 7 | 28.6 | 0 | 3 | 0.0 | 0 | 0 | 0.0 | 28.6 | -23 |
| Dec 14, 2016 | PHI | vs TOR | L 114-123 | 29 | 16 | 1 | 0 | 1 | 5 | 0 | 0 | 1 | 3 | 7 | 15 | 46.7 | 2 | 6 | 33.3 | 0 | 0 | 0.0 | 53.3 | -7 |
| Dec 08, 2016 | PHI | @ NOP | W 99-88 | 30 | 16 | 2 | 0 | 2 | 8 | 2 | 0 | 1 | 2 | 6 | 13 | 46.2 | 4 | 8 | 50.0 | 0 | 0 | 0.0 | 61.5 | +14 |
| Dec 06, 2016 | PHI | @ MEM | L 91-96 | 23 | 5 | 3 | 0 | 3 | 3 | 0 | 0 | 3 | 3 | 2 | 7 | 28.6 | 1 | 4 | 25.0 | 0 | 0 | 0.0 | 35.7 | -1 |
| Dec 05, 2016 | PHI | vs DEN | L 98-106 | 33 | 17 | 4 | 1 | 3 | 7 | 3 | 0 | 3 | 3 | 7 | 14 | 50.0 | 3 | 6 | 50.0 | 0 | 0 | 0.0 | 60.7 | +5 |
| Dec 03, 2016 | PHI | vs BOS | L 106-107 | 32 | 15 | 5 | 2 | 3 | 8 | 2 | 0 | 4 | 3 | 5 | 11 | 45.5 | 4 | 7 | 57.1 | 1 | 1 | 100.0 | 65.6 | +6 |
| Dec 02, 2016 | PHI | vs ORL | L 88-105 | 25 | 8 | 3 | 0 | 3 | 7 | 0 | 1 | 2 | 0 | 3 | 9 | 33.3 | 1 | 2 | 50.0 | 1 | 1 | 100.0 | 42.4 | -16 |
| Monthly Average | 12G | 26.5 | 11.8 | 2.8 | 0.5 | 2.3 | 5.3 | 1.1 | 0.1 | 2.2 | 2 | 4.5 | 10.4 | 43.2 | 2.4 | 5.4 | 44.6 | 0.3 | 0.4 | 80.0 | 55.8 | - |
November 2016
| Date↓ | TM | OPP | Result | MIN | PTS | REB | OREB | DREB | AST | STL | BLK | TOV | PF | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | TS% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 28, 2016 | PHI | @ TOR | L 95-122 | 28 | 11 | 3 | 1 | 2 | 7 | 2 | 0 | 4 | 2 | 4 | 7 | 57.1 | 2 | 3 | 66.7 | 1 | 1 | 100.0 | 73.9 | -25 |
| Nov 27, 2016 | PHI | vs CLE | L 108-112 | 28 | 12 | 2 | 0 | 2 | 7 | 2 | 0 | 2 | 2 | 5 | 9 | 55.6 | 2 | 3 | 66.7 | 0 | 0 | 0.0 | 66.7 | +9 |
| Nov 25, 2016 | PHI | vs CHI | L 89-105 | 14 | 0 | 3 | 1 | 2 | 3 | 0 | 0 | 3 | 2 | 0 | 4 | 0.0 | 0 | 2 | 0.0 | 0 | 0 | 0.0 | 0.0 | +4 |
| Nov 23, 2016 | PHI | vs MEM | L 99-104 | 21 | 7 | 0 | 0 | 0 | 5 | 0 | 0 | 1 | 0 | 3 | 9 | 33.3 | 1 | 3 | 33.3 | 0 | 0 | 0.0 | 38.9 | +4 |
| Nov 21, 2016 | PHI | vs MIA | W 101-94 | 20 | 9 | 0 | 0 | 0 | 5 | 0 | 0 | 3 | 1 | 4 | 4 | 100.0 | 1 | 1 | 100.0 | 0 | 0 | 0.0 | 112.5 | +3 |
| Nov 19, 2016 | PHI | vs PHX | W 120-105 | 29 | 8 | 8 | 0 | 8 | 11 | 2 | 0 | 4 | 0 | 3 | 10 | 30.0 | 2 | 6 | 33.3 | 0 | 0 | 0.0 | 40.0 | -5 |
| Nov 17, 2016 | PHI | @ MIN | L 86-110 | 24 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 3 | 2 | 0 | 4 | 0.0 | 0 | 2 | 0.0 | 0 | 0 | 0.0 | 0.0 | -20 |
| Nov 16, 2016 | PHI | vs WAS | W 109-102 | 28 | 7 | 4 | 0 | 4 | 12 | 0 | 0 | 3 | 1 | 2 | 4 | 50.0 | 0 | 1 | 0.0 | 3 | 4 | 75.0 | 60.8 | +5 |
| Nov 14, 2016 | PHI | @ HOU | L 88-115 | 27 | 2 | 2 | 0 | 2 | 6 | 1 | 1 | 1 | 0 | 1 | 8 | 12.5 | 0 | 1 | 0.0 | 0 | 0 | 0.0 | 12.5 | -17 |
| Nov 12, 2016 | PHI | @ ATL | L 96-117 | 25 | 13 | 3 | 0 | 3 | 4 | 1 | 1 | 0 | 1 | 5 | 9 | 55.6 | 3 | 4 | 75.0 | 0 | 0 | 0.0 | 72.2 | -14 |
| Nov 11, 2016 | PHI | vs IND | W 109-105 | 34 | 7 | 2 | 1 | 1 | 9 | 0 | 0 | 4 | 4 | 3 | 7 | 42.9 | 1 | 4 | 25.0 | 0 | 0 | 0.0 | 50.0 | +2 |
| Nov 09, 2016 | PHI | @ IND | L 115-122 | 31 | 2 | 2 | 1 | 1 | 5 | 3 | 0 | 2 | 1 | 1 | 14 | 7.1 | 0 | 7 | 0.0 | 0 | 0 | 0.0 | 7.1 | -12 |
| Nov 07, 2016 | PHI | vs UTA | L 84-109 | 28 | 6 | 4 | 1 | 3 | 5 | 2 | 0 | 3 | 0 | 3 | 9 | 33.3 | 0 | 4 | 0.0 | 0 | 0 | 0.0 | 33.3 | -9 |
| Nov 05, 2016 | PHI | vs CLE | L 101-102 | 31 | 7 | 6 | 0 | 6 | 11 | 2 | 0 | 3 | 1 | 3 | 9 | 33.3 | 1 | 5 | 20.0 | 0 | 0 | 0.0 | 38.9 | +2 |
| Nov 02, 2016 | PHI | @ CHA | L 93-109 | 26 | 10 | 3 | 1 | 2 | 5 | 0 | 1 | 4 | 0 | 3 | 9 | 33.3 | 3 | 7 | 42.9 | 1 | 1 | 100.0 | 53.0 | -16 |
| Nov 01, 2016 | PHI | vs ORL | L 101-103 | 32 | 12 | 5 | 0 | 5 | 11 | 0 | 0 | 4 | 2 | 5 | 11 | 45.5 | 2 | 5 | 40.0 | 0 | 0 | 0.0 | 54.5 | +4 |
| Monthly Average | 16G | 26.6 | 7.1 | 2.9 | 0.4 | 2.6 | 6.8 | 1 | 0.2 | 2.8 | 1.2 | 2.8 | 7.9 | 35.4 | 1.1 | 3.6 | 31.0 | 0.3 | 0.4 | 83.3 | 44.0 | - |
October 2016
| Date↓ | TM | OPP | Result | MIN | PTS | REB | OREB | DREB | AST | STL | BLK | TOV | PF | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | TS% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 29, 2016 | PHI | vs ATL | L 72-104 | 29 | 14 | 4 | 1 | 3 | 5 | 1 | 0 | 4 | 1 | 7 | 13 | 53.8 | 0 | 2 | 0.0 | 0 | 0 | 0.0 | 53.8 | -14 |
| Oct 26, 2016 | PHI | vs OKC | L 97-103 | 32 | 12 | 4 | 0 | 4 | 9 | 0 | 0 | 0 | 1 | 5 | 11 | 45.5 | 2 | 6 | 33.3 | 0 | 0 | 0.0 | 54.5 | +10 |
| Monthly Average | 2G | 30.5 | 13 | 4 | 0.5 | 3.5 | 7 | 0.5 | 0 | 2 | 1 | 6 | 12 | 50.0 | 1 | 4 | 25.0 | 0 | 0 | 0.0 | 54.2 | - |